191 related articles for article (PubMed ID: 30057228)
1. Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.
Turin A; Bax JJ; Doukas D; Joyce C; Lopez JJ; Mathew V; Pontone G; Shah F; Singh S; Wilber DJ; Rabbat MG
Am J Cardiol; 2018 Sep; 122(5):780-784. PubMed ID: 30057228
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
Singh JP; Kulik A; Levin R; Ellinor PT; Ruskin J; Avorn J; Choudhry NK
Europace; 2012 Sep; 14(9):1287-93. PubMed ID: 22539600
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
Huang CY; Yang YH; Lin LY; Tsai CT; Hwang JJ; Chen PC; Lin JL
Heart; 2018 Aug; 104(15):1276-1283. PubMed ID: 29371376
[TBL] [Abstract][Full Text] [Related]
4. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chaugai S; Meng WY; Ali Sepehry A
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
[TBL] [Abstract][Full Text] [Related]
7. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
Khatib R; Joseph P; Briel M; Yusuf S; Healey J
Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
[TBL] [Abstract][Full Text] [Related]
9. Age and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation.
Hung CY; Hsieh YC; Li CH; Huang JL; Lin CH; Wu TJ
Sci Rep; 2015 Jun; 5():11442. PubMed ID: 26094981
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
Lip GY; Frison L; Grind M
J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
[TBL] [Abstract][Full Text] [Related]
12. Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.
Horio T; Akiyama M; Iwashima Y; Yoshihara F; Nakamura S; Tokudome T; Okutsu M; Tanaka H; Komatsubara I; Okimoto N; Kamakura S; Kawano Y
J Hum Hypertens; 2017 Jul; 31(7):450-456. PubMed ID: 28032630
[TBL] [Abstract][Full Text] [Related]
13. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
Lau YF; Yiu KH; Siu CW; Tse HF
J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
[TBL] [Abstract][Full Text] [Related]
15. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
[TBL] [Abstract][Full Text] [Related]
17. Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation.
Ozaydin M; Dede O; Varol E; Kapan S; Turker Y; Peker O; Duver H; Ibrisim E
Int J Cardiol; 2008 Jul; 127(3):362-7. PubMed ID: 17692951
[TBL] [Abstract][Full Text] [Related]
18. Combined use of renin-angiotensin-aldosterone system-acting agents: a cross-sectional study.
Farcas A; Leucuta D; Bucsa C; Mogosan C; Dumitrascu D
Int J Clin Pharm; 2016 Dec; 38(6):1390-1397. PubMed ID: 27677980
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
